Adeyinka O Laiyemo1, Akeem O Adebogun2, Chyke A Doubeni3, Luisel Ricks-Santi4, Shelly McDonald-Pinkett2, Patrick E Young5, Brooks D Cash5, Carrie N Klabunde6. 1. Department of Medicine, Howard University College of Medicine, Washington, DC, USA; Biometry Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. Electronic address: adeyinka.laiyemo@howard.edu. 2. Department of Medicine, Howard University College of Medicine, Washington, DC, USA. 3. Department of Family Medicine and Community Health at the Perelman School of Medicine, Philadelphia, PA, USA; Leonard Davis Institute for Health Economics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA; Center for Public Health Initiatives, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. 4. Cancer Research Center, Department of Biological Sciences, Hampton University, Hampton, VA, USA. 5. Department of Medicine, Walter Reed National Military Medical Center, Bethesda, MD, USA. 6. Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Abstract
OBJECTIVES: It is unclear if provider recommendations regarding colorectal cancer (CRC) screening modalities affect patient compliance. We evaluated provider-patient communications about CRC screening with and without a specific screening modality recommendation on patient compliance with screening guidelines. METHODS: We used the 2007 Health Information National Trends Survey (HINTS) and identified 4283 respondents who were at least 50 years of age and answered questions about their communication with their care providers and CRC screening uptake. We defined being compliant with CRC screening as the use of fecal occult blood testing (FOBT) within 1 year, sigmoidoscopy within 5 years, or colonoscopy within 10 years. We used survey weights in all analyses. RESULTS: CRC screening discussions occurred with 3320 (76.2%) respondents. Approximately 95% of these discussions were with physicians. Overall, 2793 (62.6%) respondents were current with CRC screening regardless of the screening modality. Discussion about screening (odds ratio (OR)=8.83; 95% confidence interval (CI): 7.20-10.84) and providers making a specific recommendation about screening modality rather than leaving it to the patient to decide (OR=2.04; 95% CI: 1.54-2.68) were associated with patient compliance with CRC screening guidelines. CONCLUSION: Compliance with CRC screening guidelines is improved when providers discuss options and make specific screening test recommendations.
OBJECTIVES: It is unclear if provider recommendations regarding colorectal cancer (CRC) screening modalities affect patient compliance. We evaluated provider-patient communications about CRC screening with and without a specific screening modality recommendation on patient compliance with screening guidelines. METHODS: We used the 2007 Health Information National Trends Survey (HINTS) and identified 4283 respondents who were at least 50 years of age and answered questions about their communication with their care providers and CRC screening uptake. We defined being compliant with CRC screening as the use of fecal occult blood testing (FOBT) within 1 year, sigmoidoscopy within 5 years, or colonoscopy within 10 years. We used survey weights in all analyses. RESULTS: CRC screening discussions occurred with 3320 (76.2%) respondents. Approximately 95% of these discussions were with physicians. Overall, 2793 (62.6%) respondents were current with CRC screening regardless of the screening modality. Discussion about screening (odds ratio (OR)=8.83; 95% confidence interval (CI): 7.20-10.84) and providers making a specific recommendation about screening modality rather than leaving it to the patient to decide (OR=2.04; 95% CI: 1.54-2.68) were associated with patient compliance with CRC screening guidelines. CONCLUSION: Compliance with CRC screening guidelines is improved when providers discuss options and make specific screening test recommendations.
Authors: Wendy S Atkin; Rob Edwards; Ines Kralj-Hans; Kate Wooldrage; Andrew R Hart; John M A Northover; D Max Parkin; Jane Wardle; Stephen W Duffy; Jack Cuzick Journal: Lancet Date: 2010-04-27 Impact factor: 79.321
Authors: Robert E Schoen; Paul F Pinsky; Joel L Weissfeld; Lance A Yokochi; Timothy Church; Adeyinka O Laiyemo; Robert Bresalier; Gerald L Andriole; Saundra S Buys; E David Crawford; Mona N Fouad; Claudine Isaacs; Christine C Johnson; Douglas J Reding; Barbara O'Brien; Danielle M Carrick; Patrick Wright; Thomas L Riley; Mark P Purdue; Grant Izmirlian; Barnett S Kramer; Anthony B Miller; John K Gohagan; Philip C Prorok; Christine D Berg Journal: N Engl J Med Date: 2012-05-21 Impact factor: 91.245
Authors: Bernard Levin; David A Lieberman; Beth McFarland; Kimberly S Andrews; Durado Brooks; John Bond; Chiranjeev Dash; Francis M Giardiello; Seth Glick; David Johnson; C Daniel Johnson; Theodore R Levin; Perry J Pickhardt; Douglas K Rex; Robert A Smith; Alan Thorson; Sidney J Winawer Journal: Gastroenterology Date: 2008-02-08 Impact factor: 22.682
Authors: Carrie N Klabunde; David Lanier; Marion R Nadel; Caroline McLeod; Gigi Yuan; Sally W Vernon Journal: Am J Prev Med Date: 2009-05-13 Impact factor: 5.043
Authors: Jean A Shapiro; Laura C Seeff; Trevor D Thompson; Marion R Nadel; Carrie N Klabunde; Sally W Vernon Journal: Cancer Epidemiol Biomarkers Prev Date: 2008-07 Impact factor: 4.254
Authors: Beverly B Green; Melissa L Anderson; Jessica Chubak; Sharon Fuller; Richard T Meenan; Sally W Vernon Journal: Cancer Date: 2015-10-21 Impact factor: 6.860
Authors: Jane Jih; Minh P Nguyen; Irene Ly; Janice Y Tsoh; Gem M Le; Kent Woo; Elaine Chan; Ginny Gildengorin; Susan L Stewart; Adam Burke; Rena Pasick; Stephen J McPhee; Tung T Nguyen Journal: J Immigr Minor Health Date: 2018-12
Authors: Matthew A Goldshore; Shivan J Mehta; Woodrow Fletcher; George Tzanis; Chyke A Doubeni; E Carter Paulson Journal: Am J Prev Med Date: 2020-07 Impact factor: 5.043
Authors: Nancy N Baxter; Rinku Sutradhar; Qing Li; Corinne Daly; Gladys N Honein-AbouHaidar; Devon P Richardson; Lisa Del Giudice; Jill Tinmouth; Lawrence Paszat; Linda Rabeneck Journal: Am J Gastroenterol Date: 2017-02-28 Impact factor: 10.864
Authors: Emily B Peterson; Jamie S Ostroff; Katherine N DuHamel; Thomas A D'Agostino; Marisol Hernandez; Mollie R Canzona; Carma L Bylund Journal: Prev Med Date: 2016-09-28 Impact factor: 4.018